Emerging research suggests that GLP-1RAs may also be beneficial in treating conditions like obstructive sleep apnea (Malhotra et al., 2024), osteoarthritis (Bliddal et al., 2024), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis with liver fibrosis (MASH) (Loomba et al., 2024), polycystic ovary syndrome (PCOS) (Szczesnowicz et al., 2023), Alzheimers disease (Liang et al., 2024), Parkinsons disease (Kalinderi et al., 2024), and addiction (Klausen et al., 2022)
They work with the body not against it by giving instructions or signals to activate the bodys natural functions
At En Vogue IV Therapy & Wellness, our healthcare providers use BMI as a key screening tool to identify which patients will benefit most from treatments like tirzepatide
Markers studied in trials Body weight - weekly or monthly trend, not daily